Phase 1b/2a Study to Evaluate Safety and Efficacy of Setmelanotide in Obese Patients

Clinical trial NCT02041195 · COMPLETED

Trial details

NCT number: NCT02041195
Sponsor: Rhythm Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Overweight and Obesity

Start date: 2014-01-01
Primary completion: 2014-08-01
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.